Skip to main content
Article thumbnail
Location of Repository

A new look at the pathogenesis of asthma

By Stephen T. Holgate, Hasan S. Arshad, Graham C. Roberts, Peter H. Howarth, Philipp J. Thurner and Donna E. Davies


Asthma is an inflammatory disorder of the conducting airways that has strong association with allergic sensitization. The disease is characterized by a polarized Th-2 (T-helper-2)-type T-cell response, but in general targeting this component of the disease with selective therapies has been disappointing and most therapy still relies on bronchodilators and corticosteroids rather than treating underlying disease mechanisms. With the disappointing outcomes of targeting individual Th-2 cytokines or manipulating T-cells, the time has come to re-evaluate the direction of research in this disease. A case is made that asthma has its origins in the airways themselves involving defective structural and functional behaviour of the epithelium in relation to environmental insults. Specifically, a defect in barrier function and an impaired innate immune response to viral infection may provide the substrate upon which allergic sensitization takes place. Once sensitized, the repeated allergen exposure will lead to disease persistence. These mechanisms could also be used to explain airway wall remodelling and the susceptibility of the asthmatic lung to exacerbations provoked by respiratory viruses, air pollution episodes and exposure to biologically active allergens. Variable activation of this epithelial-mesenchymal trophic unit could also lead to the emergence of different asthma phenotypes and a more targeted approach to the treatment of these. It also raises the possibility of developing treatments that increase the lung's resistance to the inhaled environment rather than concentrating all efforts on trying to suppress inflammation once it has become established.<br/><br/

Topics: QR180, QR355, RB
Year: 2009
OAI identifier:
Provided by: e-Prints Soton

Suggested articles


  1. (1998). A 15-year follow-up study of ventilatory function in adults with asthma. doi
  2. (2003). A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. doi
  3. (2007). A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. doi
  4. (2005). A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. doi
  5. (2008). Achieving asthma control in practice: understanding the reasons for poor control. doi
  6. (2009). Airway epithelium stimulates smooth muscle proliferation, doi
  7. (2008). Airway hyperresponsiveness is dissociated from airway wall structural remodeling. doi
  8. (2001). Airway inflammation is present during clinical remission of atopic asthma. doi
  9. (2005). Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. doi
  10. (2009). Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. doi
  11. (2009). Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. doi
  12. (2008). Altered expression of epithelial junctional proteins in atopic asthma: possible role in inflammation. doi
  13. (2006). Asthma during the primary school ages: prevalence, remission and the impact of allergic sensitization.
  14. (2002). Asthma: more than an inflammatory disease. doi
  15. (2005). Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
  16. (2002). Asthmatic bronchial epithelium is more susceptible to oxidant-induced apoptosis. doi
  17. (2008). B o n e r ,A .L . doi
  18. (1979). Biologic implications of the structural and functional characteristics of the chemical mediators of immediate-type hypersensitivity.
  19. (2007). Biophysical basis for airway hyperresponsiveness. doi
  20. (2009). Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches. doi
  21. (2008). British Society for Allergy and Clinical Immunology guidelines for the management of allergic and non-allergic rhinitis. doi
  22. (2003). Bronchial hyperresponsiveness and airway inflammation in adolescents with asymptomatic childhood asthma. doi
  23. (2007). Can asthma control be improved by understanding the patient’s perspective? doi
  24. (2009). Cell stiffness, contractile stress and the role of extracellular matrix. doi
  25. (2008). Cluster analysis and clinical asthma phenotypes. doi
  26. (2003). Control of exposure to mite allergen and allergen-impermeable bed covers for adults with asthma. doi
  27. (2005). Daily versus as-needed corticosteroids for mild persistent asthma. doi
  28. (2001). Dendritic cells in the mucosa of the human trachea are not regularly found in the first year of life. doi
  29. (1999). Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. doi
  30. (2007). Determinants of response to fluticasone propionate and salmeterol/ fluticasone propionate combination in the Gaining Optimal Asthma controL study. doi
  31. (2002). Development of wheezing disorders and asthma in preschool children.
  32. (2009). Do childhood respiratory infections continue to influence adult respiratory morbidity? doi
  33. (2008). Dysregulated repair in asthmatic paediatric airway epithelial cells: the role of plasminogen activator inhibitor-1. doi
  34. (2005). Early changes in basement membrane thickness in airway walls post-lung transplantation, doi
  35. (2007). Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. doi
  36. (2007). Early life influences on the development of allergy and asthma -how early is early? doi
  37. (2005). Early life risk factors for current wheeze, asthma, and bronchial hyperresponsiveness at doi
  38. (2004). Endobronchial ultrasound to assess airway wall thickening: validation in vitro and in vivo.E u r .R e s p i r .J . doi
  39. (2008). Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. doi
  40. (2006). Enhanced upregulation of smooth muscle related transcripts by TGFβ2 in asthmatic (myo)fibroblasts. doi
  41. (2008). Epidemiology of asthma exacerbations. doi
  42. (2006). Epithelial damage and angiogenesis in the airways of children with asthma. doi
  43. (2005). Epithelial stress and structural remodelling in childhood asthma. doi
  44. (2000). Epithelial-mesenchymal interactions in the pathogenesis of asthma. doi
  45. (2007). Epithelium dysfunction in asthma. doi
  46. (2004). Establishment of FUT8 knockout Chinese hamster ovary cells: an ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity. doi
  47. (2008). Evidence of a causal role of winter virus infection during infancy in early childhood asthma. doi
  48. (1990). Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. doi
  49. (2006). Extracellular matrix remodeling by dynamic strain in a three-dimensional tissue-engineered human airway wall model. doi
  50. (2003). Factors influencing symptom expression in children with bronchial hyperresponsiveness at 10 years of age. doi
  51. (2009). Fibrocyte localization to the airway smooth muscle is a feature of asthma. doi
  52. (2008). Filaggrin in atopic dermatitis. doi
  53. (2007). Friendly and dangerous signals: is the tissue in control? doi
  54. (2007). Gender differences in asthma development and progression. doi
  55. (2001). H e w i t t ,E .L . ,L a m o n t ,A .G . ,D a v i e s ,R .J .a n dL o z e w i c z , S. doi
  56. (2005). High-resolution computed tomography scan and airway remodeling in children with severe asthma. doi
  57. (1999). How much asthma is really attributable to atopy? doi
  58. (2007). i m ,E .S . ,K i m ,S .H . ,K i m ,K .W . ,P a r k doi
  59. (2003). Increased expression of p21waf cyclin-dependent kinase inhibitor in asthmatic bronchial epithelium. doi
  60. (2009). Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-β1. doi
  61. (2007). Inflammation of bronchial smooth muscle in allergic asthma. doi
  62. (2009). Intestinal barrier function: molecular regulation and disease pathogenesis doi
  63. (1996). Is there a role for immunotherapy in the treatment of asthma? doi
  64. (2007). Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. doi
  65. (2006). Long-term inhaled corticosteroids in preschool children at high risk for asthma. doi
  66. (2006). Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex.
  67. (2002). Mast-cell infiltration of airway smooth muscle in asthma. doi
  68. (2003). Mechanical stress triggers selective release of fibrotic mediators from bronchial epithelium. doi
  69. (2009). Mepolizumab and exacerbations of refractory eosinophilic asthma. doi
  70. (2009). Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. doi
  71. (2008). Natural history of asthma: persistence versus progression: does the beginning predict the end? doi
  72. (2008). Nonatopic children with multitrigger wheezing have airway pathology comparable to atopic asthma. doi
  73. (2009). Novel targets of therapy in asthma. doi
  74. (2005). Outcome of asthma and wheezing in the first 6 years of life: follow-up through adolescence. doi
  75. (2008). Oxidant–antioxidant imbalance in asthma: scientific evidence, epidemiological data and possible therapeutic options. doi
  76. (2006). Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. doi
  77. (2007). Persistence and remission in childhood asthma: a population-based asthma birth cohort study. doi
  78. (2005). Polymorphisms in a disintegrin and metalloprotease 33 (ADAM33) predict impaired early-life lung function. doi
  79. (2008). Predicting risk of asthma in wheezing infants.
  80. (2006). Reduced lung function at birth and the risk of asthma at 10 years of age. doi
  81. (2008). Rhinovirus disrupts the barrier function of polarized airway epithelial cells. doi
  82. (2008). Rhinovirus infection and house dust mite exposure synergize in inducing bronchial epithelial cell interleukin-8 release. doi
  83. (2008). Risk factors associated with irreversible airflow limitation in asthma. doi
  84. (2006). Role of deficient type III interferon-λ production in asthma exacerbations. doi
  85. (2006). Role of small airways in asthma: investigation using high-resolution computed tomography. doi
  86. (2006). Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. doi
  87. (2007). Severe asthma: lessons from the Severe Asthma Research Program. doi
  88. (2004). Small size at birth and greater postnatal weight gain: relationships to diminished infant lung function. doi
  89. (2005). Smooth muscle actin determines mechanical force-induced p38 activation. doi
  90. (2007). Specificity of basement membrane thickening in severe asthma. doi
  91. (2008). Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma. doi
  92. (2008). Still more questions than answers. Lancet doi
  93. (2006). The asthma epidemic. doi
  94. (2010). The Authors Journal compilation C doi
  95. (2007). The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries.
  96. (2008). The Brussels Declaration: the need for change in asthma management. doi
  97. (2004). The immunogenetics of asthma and eczema: a new focus on the epithelium. doi
  98. (1989). The mechanics of airway narrowing in asthma. doi
  99. (2007). Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. doi
  100. (2008). Thymic stromal lymphopoietin: a new cytokine in asthma. doi
  101. (2009). Treatment of a case of pediatric hypereosinophilic syndrome with anti-interleukin-5. doi
  102. (2008). Treatment of patients with the hypereosinophilic syndrome with mepolizumab. doi
  103. (2009). What if it is the other way around? Early introduction of peanut and fish seems to be better than avoidance. doi
  104. (2008). Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study. doi
  105. (2008). Wheezing in childhood: incidence, longitudinal patterns and factors predicting persistence. doi
  106. (2008). Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. doi
  107. years of age. doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.